(MENAFN- Baystreet) RH Stock Surges After Earnings
Home Depot To Acquire SRS Distribution For $18.25 Billion
Krispy Kreme Stock Surges After McDonald's Deal
GE Vernova's Stock Rises 14% In Market Debut
Stock News Alerts: Xiaomi's EVs, Fast Food Restaurants, and Inflation Previous Articles Subscribe to Get Small Cap News & Alerts Ambrose O'Callaghan - Thursday, March 28, 2024
Shockwave Medical Stock Rises Amid Johnson & Johnson Acquisition Reports
Shockwave Medical (NASDAQ:SWAV) is a Santa Clara-based medical device company that is engaged in the development and commercialization of intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United States and around the world. Shares of Shockwave Medical have shot up 13% week-over-week as of late morning trading on Wednesday, March 27. What is behind this recent price action? Let's jump in.
On Tuesday, March 26, the Wall Street Journal reported that Johnson & Johnson was in talks to buy the medical device maker. Johnson & Johnson has sought to expand its presence in cardiovascular devices, considering the potential in this space.
A recent report from Grand View Research estimated that the global cardiovascular devices market was valued at US$48.5 billion in 2022. The same report projected that this industry was anticipated to grow at a compound annual growth rate (CAGR) of 7.1% from 2023 through to 2030. Cardiovascular devices play a crucial role in detecting and mitigating heart disease, the leading cause of death worldwide.
Shockwave Medical released its fourth quarter (Q4) and full year 2023 results on February 15, 2024. The company recognized revenue of $203 million in Q4 2023 and $730 million for the full year. That represented increases of 41% and 49%, respectively, compared to the same period in fiscal 2022. Shockwave also initiated the full U.S. commercial launch of the Shockwave C2+ Coronary Intravascular Lithotripsy (IVL) catheter.
About Us Contact Us Advertise License Our Content Jobs Disclaimer Privacy Policy
Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks
MENAFN28032024000212011056ID1108032331
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.